Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    11818490 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women
Condition: HIV Infections
Intervention:
2 Completed Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers
Condition: Healthy Volunteer
Intervention: Drug: Raltegravir
3 Completed Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults
Condition: HIV Infections
Interventions: Drug: Emtricitabine;   Drug: Enfuvirtide;   Drug: Ritonavir;   Drug: Saquinavir;   Drug: Tenofovir disoproxil fumarate
4 Completed A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women
Conditions: HIV;   AIDS
Intervention: Drug: Raltegravir (Isentress®)

Indicates status has not been verified in more than two years